AGC Biologics
Global CDMO providing biopharmaceutical development and manufacturing services.
Company facts
- Founded
- 2018
- Employees
- 2,500
- Headquarters
- United States
- Type
- Private
- Funding
- Corporate Round · $194M · 2024
- Subsidiaries
- AGC Biologics S.p.A., AGC Biologics Germany GmbH, AGC Biologics Denmark A/S
About
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA, mRNA, viral vectors, and genetically engineered cells. With cGMP-compliant facilities across the U.S., Europe, and Asia, AGC Biologics offers comprehensive services including cell line development, upstream and downstream process development, analytical development, formulation, and manufacturing. The company's focus on delivering expert, friendly service and maintaining the highest standards of quality makes it a distinctive player in the biopharmaceutical industry.